论文信息 - Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic - 字舞流文

Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic

Yasuhiko Tsukada | J. Saito | T. Ishii | Y. Tanino | T. Umeda | H. Ohtani | K. Sugino | T. Nikaido | A. Fukuhara | R. Kanno | Y. Inokoshi | J. Morimoto | T. Azuma | K. Iseki | E. Sando | M. Nakayama | Yasuhito Suzuki | N. Watanabe | R. Togawa | H. Minemura | K. Tanigawa | M. Kamimoto | H. Tomita | Tatsuho Kobayashi | Mitsuru Waragai | Y. Shibata | N. Kanzaki | Riko Sato | Hiroyuki Saito | H. Kume | T. Ishida | Ryuki Yamada | T. Onuma | Kiyoshi Saito | Masahiko Sato | H. Sakuma | Y. Nakamura | Keiji Sakamoto | Y. Sato | Kenya Kanazawa | Shinsaku Maeda | Mami Rikimaru | Mikako Saito | Takaya Kawamata | Shuzo Suzuki | Hideko Aoki | Akira Takama | T. Kamiyama | Toshiyuki Kanbe | Yayoi Inokoshi | Yoko Shibata | T. Ishii | Mikako Saito | Y. Nakamura | S. Suzuki | H. Aoki | A. Takama | M. Waragai